RepliCel Announces its Incoming Board of Directors

Successful Annual General Meeting Confirms Director Slate for 2020 VANCOUVER, Dec. 23, 2019 /PRNewswire/ – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.